Moderna, Inc.
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the Uni…
Biotechnology
US, Cambridge [HQ]
Ratios
8 Sheets · Starting from 2023Margins, Growth Rates In %
| Ratio | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||
| Gross Margin | 100.00 | 100.00 | -270.64 | 35.42 | 97.11 | 85.24 | 71.88 | 30.52 | |
| Profit Margin | -212.94 | -144.61 | -314.04 | -1,070.07 | -272.16 | 68.80 | 43.41 | -69.80 | |
| Operating Margin | -220.39 | -152.20 | -337.33 | -1,136.06 | -278.02 | 74.97 | 48.90 | -62.76 | |
|
EPS Growth
|
- - | -17.24 | -597.06 | 67.30 | -26.45 | 1,644.90 | -29.92 | -158.15 | |
| EPS USD | -58.00 | -68.00 | -474.00 | -155.00 | -196.00 | 3,028.00 | 2,122.00 | -1,234.00 | |
| Return on Assets (ROA) | -15.26 | -23.60 | -19.61 | -32.34 | -10.18 | 49.46 | 32.34 | -25.58 | |
| Return on Equity (ROE) | -25.68 | -40.93 | -25.14 | -43.75 | -29.17 | 86.26 | 43.73 | -34.03 | |
| Return on Invested Capital (ROIC) | -25.57 | -37.73 | -25.18 | -39.64 | -23.65 | 81.08 | 40.48 | -33.58 | |
| Solvency | |||||||||
| Equity Ratio | - - | - - | - - | - - | - - | - - | - - | - - | |
| Debt/Assets | 2.65 | 8.15 | 5.74 | 12.58 | 9.23 | 3.71 | 4.64 | 6.75 | |
| Debt/Equity | 4.46 | 14.14 | 7.36 | 17.03 | 26.43 | 6.48 | 6.28 | 8.97 | |
| Debt/EBITDA | 18.01 | 47.90 | 151.20 | 18.97 | 316.66 | -44.62 | -20.53 | 51.82 | |
|
Debt/Capitalization
|
4.27 | 12.39 | 6.85 | 14.55 | 20.90 | 6.08 | 5.90 | 8.23 | |
| Long-Term Debt/Capitalization | 1.46 | 2.45 | 2.14 | 10.13 | 7.49 | 4.75 | 4.99 | 8.08 | |
| Interest Debt per Share USD | 0.10 | 0.24 | 1.39 | 0.62 | 1.80 | 2.32 | 3.12 | 3.35 | |
| Debt Growth | - - | 25.50 | 113.48 | 295.25 | 56.61 | 341.88 | 31.00 | 3.58 | |
| Liquidity | |||||||||
| Current Ratio | 667.78 | 409.08 | 701.52 | 882.50 | 143.50 | 192.48 | 272.82 | 342.45 | |
| Quick Ratio | 660.98 | 403.57 | 696.58 | 782.10 | 137.12 | 153.63 | 229.27 | 321.23 | |
| Cash Ratio | 30.76 | 70.44 | 295.49 | 164.82 | 59.79 | 75.02 | 65.10 | 96.42 | |
| Operating Cash Flow Ratio | - - | -100 | -100 | -300 | - - | 100 | 100 | -100 | |
| Turnover | |||||||||
| Inventory Turnover | - - | - - | -262.49 | -3.43 | 17.05 | 181.61 | 570.71 | 2,323.27 | |
| Receivables Turnover | 565.63 | 1,062.52 | 400.59 | 294.75 | 19.46 | 538.11 | 1,390.83 | 624.79 | |
| Payables Turnover | - - | - - | 1,454.93 | 437.53 | 43.21 | 866.56 | 1,112.12 | 902.50 | |
|
Asset Turnover
|
7.16 | 16.32 | 6.24 | 3.02 | 3.74 | 71.90 | 74.50 | 36.65 | |
| Fixed Turnover | 125.03 | 127.29 | 57.79 | 16.68 | 70.91 | 1,282.43 | 900.56 | 254.10 | |
| Coverage | |||||||||
| Interest Coverage | - - | - - | - - | -8,253.48 | -7,719.44 | 73,866.67 | 32,482.76 | -11,155.26 | |
| Asset Coverage | 10,200 | 6,100 | 5,400 | 1,100 | 1,600 | 1,700 | 1,700 | 1,200 | |
| Cash Flow Coverage (CFGR) | 177.71 | -374.97 | -293.94 | -229.47 | 299.46 | 1,486.90 | 415.08 | -250.84 | |
| EBITDA Coverage | - - | - - | - - | -8,200 | -7,700 | 73,800 | 33,600 | -8,400 | |
| Dividend Coverage | - - | - - | - - | - - | - - | - - | - - | - - | |
| Time Interest Earned (TIE) | - - | - - | - - | - - | - - | 800 | 300 | - - | |
| Market Prospects | |||||||||
| Dividend Yield | - - | - - | - - | - - | - - | - - | - - | - - | |
| Earnings Yield | -3.09 | -3.66 | -31.06 | -7.94 | -1.88 | 11.92 | 11.82 | -12.41 | |
|
Price/Earnings (P/E)
|
-3,234.62 | -2,732.77 | -321.94 | -1,258.80 | -5,332.59 | 838.83 | 846.33 | -805.90 | |
| Price/Earnings Growth (PEG) | - - | -158.50 | -0.54 | 18.70 | -201.60 | -0.51 | -28.29 | 5.10 | |
|
Price/Book (P/B)
|
830.74 | 1,118.45 | 80.94 | 550.77 | 1,555.33 | 723.61 | 370.08 | 274.22 | |
| Price/Tangible Book (P/TB) | 830.74 | 1,118.45 | 80.94 | 550.77 | 1,555.33 | 723.61 | 370.08 | 274.22 | |
| Price/Sales (P/S) | 6,887.80 | 3,951.77 | 1,011.01 | 13,470.08 | 14,513.41 | 577.10 | 367.39 | 562.48 | |
|
Price/Cash Flow (P/CF)
|
10,479.82 | -2,109.79 | -374.36 | -1,409.79 | 1,965.39 | 751.50 | 1,420.80 | -1,218.41 | |
| Price/Free CF (P/FCF) | 20,820.48 | -1,793.76 | -283.68 | -1,319.10 | 2,033.04 | 767.50 | 1,544.87 | -993.20 | |
| Price/Operating CF (P/OCF) | 10,479.82 | -2,109.79 | -374.36 | -1,409.79 | 1,965.39 | 751.50 | 1,420.80 | -1,218.41 |